AFP and hepatocellular carcinoma: Increased serum alpha-fetoprotein (AFP) levels are associated withspecific molecular sub-classes of hepatocellular carcinoma (HCC), supportingAFP as a predictive or therapeutic biomarker for precision treatment of thisdisease.